Epidemiology & Risk Factors

  • Etiology: Trichinella spiralis (nematode/roundworm).
  • Transmission: Ingestion of raw or undercooked meat containing encysted larvae.
    • Domestic source: Undercooked pork.
    • Sylvatic source: Wild game (e.g., bear, wild boar, walrus).
  • Pathophysiology: Ingested larvae liberated in stomach -> mature in small intestine -> female worms release newborn larvae -> hematogenous spread to skeletal muscle -> encystment.

Clinical Features

  • Phase 1: Intestinal Stage (1–2 weeks post-ingestion):
    • Nausea, vomiting, abdominal pain, diarrhea.
    • Often mild or transient.
  • Phase 2: Muscle Invasiveness / Systemic Stage (2–8 weeks post-ingestion):
    • Classic Triad: Periorbital edema + Myositis (severe muscle pain/tenderness) + Fever.
    • Subungual splinter hemorrhages and conjunctival hemorrhages. c
    • Chemosis, macular or maculopapular rash.
    • Muscle pain involving extraocular, masseter, neck, and proximal limb muscles.

Diagnosis

  • Initial / Screening Labs:
    • Marked Eosinophilia (often >20–50%; hallmark finding).
    • ↑ Creatine kinase (CK), ↑ LDH, ↑ Aldolase (indicates myositis).
    • ↑ Serum IgE level.
  • Confirmatory / Gold Standard:
    • Serology (ELISA): Anti-Trichinella Ab detection (mainstay; usually positive 2–3 weeks post-infection).
    • Muscle Biopsy: Demonstrates encysted larvae within striated muscle (definitive; reserved for diagnostic ambiguity or negative serology w/ high clinical suspicion).

Differential Diagnostics

  • Polymyositis / Dermatomyositis: Diff by chronic onset, lack of GI prodrome, absence of eosinophilia, and positive autoantibodies (e.g., anti-Jo-1, anti-Mi-2).
  • Periorbital Cellulitis: Diff by localized warmth/erythema, typically unilateral, and absence of eosinophilia or systemic myositis.
  • Typhoid Fever: Diff by persistent high fever, rose spots, leukopenia (not eosinophilia), and positive blood/stool cultures.
  • Eosinophilic Granulomatosis with Polyangiitis (EGPA): Diff by history of severe asthma, allergic rhinitis, p-ANCA positivity, and pulmonary infiltrates.

Management

  1. Mild / Asymptomatic Disease:
    • Symptomatic treatment with NSAIDs for analgesia and fever control.
  2. Moderate to Severe / Early Disease:
    • Antiparasitic therapy: Albendazole (400 mg PO BID for 10–14 days) or Mebendazole.
  3. Severe Disease / Organ Involvement (e.g., myocarditis, CNS involvement, severe hyper-inflammation):
    • High-dose Corticosteroids (e.g., Prednisone) co-administered with antiparasitics to prevent severe immune reactions to dying larvae.

Complications

  • Myocarditis: Leading cause of death (arrhythmias, heart failure, ECG changes).
  • Encephalitis / Meningoencephalitis: Seizures, focal neurological deficits, altered mental status.
  • Pneumonitis / Diaphragmatic weakness: Respiratory failure secondary to larval migration into respiratory muscles.